Free Trial
Louise Chen

Louise Chen Analyst Performance

Managing Director at Scotiabank

Louise Chen is a stock analyst at Scotiabank in the medical sector, covering 43 publicly traded companies. Over the past year, Louise Chen has issued 8 stock ratings, including buy and hold recommendations. While full access to Louise Chen's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Louise Chen's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
329 Last 11 Years
Buy Recommendations
94.48% 308 Buy Ratings
Companies Covered
43 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy94.5%308 ratings
Hold5.5%18 ratings
Sell0.0%0 ratings

Out of 326 total stock ratings issued by Louise Chen at Scotiabank, the majority (94.5%) have been Buy recommendations, followed by 5.5% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
74.4% of companies on NASDAQ
32 companies
NYSE
20.9% of companies on NYSE
9 companies
NYSEAMERICAN
2.3% of companies on NYSEAMERICAN
1 company
OTCMKTS
2.3% of companies on OTCMKTS
1 company

Louise Chen, an analyst at Scotiabank, currently covers 43 companies listed on NASDAQ, NYSE, NYSEAMERICAN and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
43 companies
100.0%

Louise Chen of Scotiabank specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
18 companies
41.9%
MED - DRUGS
10 companies
23.3%
LARGE CAP PHARMA
5 companies
11.6%
PHARMACEUTICAL PREPARATIONS
4 companies
9.3%
MED - GENERIC DRG
2 companies
4.7%
MED PRODUCTS
2 companies
4.7%
SURGICAL & MEDICAL INSTRUMENTS
1 company
2.3%
MED INSTRUMENTS
1 company
2.3%

Louise Chen's Ratings History at Scotiabank

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/13/2026Boost Price Target$496.69$558.00Outperform
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
1/29/2026Boost Price Target$32.43$40.00Sector Outperform
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
1/22/2026Reiterated Rating$219.71Outperform
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
1/22/2026Boost Price Target$219.87$265.00Sector Outperform
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
1/9/2026Reiterated Rating$55.65$60.00Sector Perform
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
12/5/2025Initiated Coverage$28.39$35.00Sector Outperform
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
12/4/2025Boost Price Target$101.29$120.00Sector Outperform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
11/24/2025Boost Price Target$770.08$770.00Sector Perform
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
3/7/2025Initiated Coverage$10.79$30.00Sector Outperform
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
3/7/2025Initiated Coverage$30.35$70.00Sector Outperform
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
3/7/2025Initiated Coverage$88.54$150.00Sector Outperform
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
3/7/2025Initiated Coverage$7.41$17.00Sector Outperform
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
3/7/2025Initiated Coverage$12.24$50.00Sector Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
3/7/2025Initiated Coverage$28.13$50.00Sector Outperform
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
3/7/2025Initiated Coverage$2.70$15.00Sector Outperform
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
3/7/2025Initiated Coverage$35.39$55.00Sector Outperform
Gain Therapeutics, Inc. stock logo
GANX
Gain Therapeutics
3/7/2025Initiated Coverage$1.80$12.00Sector Outperform
Innoviva, Inc. stock logo
INVA
Innoviva
3/7/2025Initiated Coverage$17.59$55.00Sector Outperform
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
3/7/2025Initiated Coverage$23.94$50.00Sector Outperform
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
3/7/2025Initiated Coverage$52.80$55.00Sector Perform
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
3/7/2025Initiated Coverage$103.03$105.00Sector Perform
Ardelyx, Inc. stock logo
ARDX
Ardelyx
3/7/2025Initiated Coverage$5.30$15.00Sector Outperform
Aclaris Therapeutics, Inc. stock logo
ACRS
Aclaris Therapeutics
3/7/2025Initiated Coverage$1.83$15.00Sector Outperform